MEDP logo

Medpace Holdings (MEDP) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

11 August 2016

Indexes:

Not included

Description:

Medpace Holdings, Inc. specializes in conducting contract clinical research for companies in the biotechnology, pharmaceutical, and medical industries. It was founded in 1992. The headquarters is located in Cincinnati, Ohio (USA). Medpace Holdings, Inc. provides a wide range of services: monitoring clinical trials, laboratory analysis, electronic data capture, patient recruitment, and more. The company conducts scientific research on new drugs and medical devices in key therapeutic areas such as cardiology, hematology, oncology, neurology and psychiatry, vaccine development, antibiotics, etc. Clients of Medpace Holdings, Inc. include many leading global pharmaceutical, biotechnology companies, and medical device manufacturers.

Events Calendar

Earnings

Next earnings date:

Feb 10, 2025

Recent quarterly earnings:

Oct 21, 2024

Recent annual earnings:

Feb 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

25 Nov '24 Baird
Neutral
23 Oct '24 TD Cowen
Buy
23 Oct '24 Baird
Neutral
22 Oct '24 William Blair
Outperform
14 Oct '24 Truist Securities
Hold
14 Oct '24 Redburn Atlantic
Buy
27 Sept '24 UBS
Neutral
25 Sept '24 Jefferies
Hold
20 Sept '24 Baird
Outperform
11 Sept '24 William Blair
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
MEDP
accesswire.com05 January 2025

LOS ANGELES, CA / ACCESSWIRE / January 5, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.

Medpace Holdings Inc Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings Inc Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings Inc Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
MEDP
accesswire.com04 January 2025

LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

The Schall Law Firm Invites Shareholders To Join An Inquiry Into Medpace Holdings Inc For Securities Law Violations
The Schall Law Firm Invites Shareholders To Join An Inquiry Into Medpace Holdings Inc For Securities Law Violations
The Schall Law Firm Invites Shareholders To Join An Inquiry Into Medpace Holdings Inc For Securities Law Violations
MEDP
accesswire.com03 January 2025

LOS ANGELES, CA / ACCESSWIRE / January 3, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
MEDP
accesswire.com28 December 2024

LOS ANGELES, CA / ACCESSWIRE / December 28, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
MEDP
accesswire.com27 December 2024

LOS ANGELES, CA / ACCESSWIRE / December 27, 2024 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
MEDP
accesswire.com26 December 2024

LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
MEDP
zacks.com24 December 2024

This is a comparison of how Medpace (MEDP) and Clover Health Investments, Corp. (CLOV) have done in relation to their industry this year.

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
MEDP
accesswire.com24 December 2024

LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

Medpace (MEDP) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Medpace (MEDP) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Medpace (MEDP) Rises Yet Lags Behind Market: Some Facts Worth Knowing
MEDP
zacks.com23 December 2024

Medpace (MEDP) finished the last trading day at $339.05, which is an increase of 0.52% compared to the day before.

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
MEDP
accesswire.com21 December 2024

LOS ANGELES, CA / ACCESSWIRE / December 21, 2024 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.

FAQ

  • What is the primary business of Medpace Holdings?
  • What is the ticker symbol for Medpace Holdings?
  • Does Medpace Holdings pay dividends?
  • What sector is Medpace Holdings in?
  • What industry is Medpace Holdings in?
  • What country is Medpace Holdings based in?
  • When did Medpace Holdings go public?
  • Is Medpace Holdings in the S&P 500?
  • Is Medpace Holdings in the NASDAQ 100?
  • Is Medpace Holdings in the Dow Jones?
  • When was Medpace Holdings's last earnings report?
  • When does Medpace Holdings report earnings?
  • Should I buy Medpace Holdings stock now?

What is the primary business of Medpace Holdings?

Medpace Holdings, Inc. specializes in conducting contract clinical research for companies in the biotechnology, pharmaceutical, and medical industries. It was founded in 1992. The headquarters is located in Cincinnati, Ohio (USA). Medpace Holdings, Inc. provides a wide range of services: monitoring clinical trials, laboratory analysis, electronic data capture, patient recruitment, and more. The company conducts scientific research on new drugs and medical devices in key therapeutic areas such as cardiology, hematology, oncology, neurology and psychiatry, vaccine development, antibiotics, etc. Clients of Medpace Holdings, Inc. include many leading global pharmaceutical, biotechnology companies, and medical device manufacturers.

What is the ticker symbol for Medpace Holdings?

The ticker symbol for Medpace Holdings is NASDAQ:MEDP

Does Medpace Holdings pay dividends?

No, Medpace Holdings does not pay dividends

What sector is Medpace Holdings in?

Medpace Holdings is in the Healthcare sector

What industry is Medpace Holdings in?

Medpace Holdings is in the Diagnostics & Research industry

What country is Medpace Holdings based in?

Medpace Holdings is headquartered in United States

When did Medpace Holdings go public?

Medpace Holdings's initial public offering (IPO) was on 11 August 2016

Is Medpace Holdings in the S&P 500?

No, Medpace Holdings is not included in the S&P 500 index

Is Medpace Holdings in the NASDAQ 100?

No, Medpace Holdings is not included in the NASDAQ 100 index

Is Medpace Holdings in the Dow Jones?

No, Medpace Holdings is not included in the Dow Jones index

When was Medpace Holdings's last earnings report?

Medpace Holdings's most recent earnings report was on 21 October 2024

When does Medpace Holdings report earnings?

The next expected earnings date for Medpace Holdings is 10 February 2025

Should I buy Medpace Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions